• Investment

    • Frontier Pharma leverages extensive pharma industry expertise across the entire pharma value chain (from development to commercialisation) to identify and invest in high quality pharmaceutical businesses in high growth markets across CEE, Middle East, Sub-Saharan Africa and Central America
    • We have a track record in fully integrated US FDA approved manufacturing and experience with producing and commercialising
      complex biologic, oncolytic and consumer health products across high growth markets
    • We have an extensive network across large developed and high growth emerging markets which can be leveraged to internationalise
      businesses via exports or strategic alliances and gain access to value-creating business development opportunities such as
      product licensing or acquisitions
    • Frontier Pharma is well-suited to lead operational and financial restructuring of under-performing or distressed companies in the sector
  • Advisory

    • Frontier Pharma has a high quality strategic advisory platform focused on business development and mergers & acquisitions in high growth markets often underserved by traditional advisors
    • We have a track record and credentials in advising blue-chip financial and strategic clients in Central & Eastern Europe, Turkey, Russia/CIS, Turkey, Western Europe, Middle East, South Africa and Latin America
    • We combine top-tier investment banking (e.g. M&A, financing) and senior sector (e.g. business development, due diligence) experience to provide a comprehensive service offering
    • Frontier Pharma has a wide global network that can be leveraged to support expansion or divestments in an efficient and confidential way